Skip to main content
Asston Pharmaceuticals IPO
180.30xsubscribed

Asston Pharmaceuticals IPO

Pharmaceuticals & Drugs
listed
₹2.30LMin. investment

Asston Pharmaceuticals Limited IPO Details

SectorPharmaceuticals & Drugs
Price range₹115 – ₹123
IPO type
SME
Lot size1000 shares
Issue size₹27Cr
Draft Red Herring Prospectus
Read
Market cap
₹104.7CrLower than sector avg
RevenueApr 2024 - Mar 2025
₹25.04CrLower than sector avg
Growth rate3Y CAGR
95.67%

Asston Pharmaceuticals IPO Subscription Status

Date
QIB
NII
Retail
Total
09-Jul-25
3.51 times (X)
0.66 times (X)
1.22 times (X)
1.75 times (X)
10-Jul-25
4.47X
19.32X
16.66X
13.77X
11-Jul-25
85.76X
328.69X
170.1X
180.3X

As on 09-Jul-25, 5:30 PM

Asston Pharmaceuticals IPO Timeline

  1. Pre-apply
    8 Jul 2025
  2. Bid start
    9 Jul 2025
  3. Bid end
    11 Jul 2025
  4. Allotment
    14 Jul 2025
  5. Release of funds
    15 Jul 2025
  6. Demat transfer
    15 Jul 2025
  7. Listing
    16 Jul 2025

About Asston Pharmaceuticals Limited

Incorporated in 2019, Asston Pharmaceuticals manufactures and exports pharmaceutical formulations and nutraceutical products for domestic and African markets. It operates through export sales, contract manufacturing/license sales, and domestic sales. The company’s Ambernath facility has a capacity of 8-9 crore tablets/month (currently 5-6 crore), 37.5 KL/month syrup, and 30-40 lakh sachets/month. It has five WHO-GMP-certified contract manufacturers under 5-year agreements and holds 150+ trademarks. Asston has 147 product registrations in African markets (Sierra Leone, Mali, Liberia, Ghana) and 10 filed in Cambodia, covering tablets, syrups, capsules, sachets, ophthalmic products, and creams. As of May 31, 2025, its order book stands at $4.75 million (₹40.86 crore) from 12 customers.

Checklist

Quality analysis
Revenue growth
Company valuation
Earnings expansion
Risk analysis
Debt to Equity ratio
Promoter holdings
Shares pledged
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Objectives of Asston Pharmaceuticals Limited IPO

Working capital
47.10%
The company will utilise ₹13 crore to meet working capital requirements.
General corporate purposes
27.40%
Part of the IPO proceeds will be used for general corporate purposes.
Capital expenditure
21.70%
The company will use ₹6 crore to acquire machinery in the manufacturing unit.
Repayment of loans
3.60%
₹1 crore from net proceeds will be used to repay borrowings.

Compare

CompanyRevenue*3Y growthPATMarket capP/E ratioD/E ratio
This IPO₹25.04Cr95.67%₹4.33Cr₹104.7Cr17.830.65
This sector (avg.)₹1,331.47Cr0%₹193.4Cr₹10,914.84Cr60.870.43
₹52,578.44Cr---₹10,980.1Cr₹3,82,765.9Cr36.980.03
₹9,360Cr---₹2,191Cr₹1,60,635Cr64.600
₹11,516.09Cr---₹1,911.25Cr₹1,34,051.5Cr62.640.42

*Revenue for financial year 2024-25. Lower P/E and D/E ratios are generally preferred.

Asston Pharmaceuticals IPO Contact Details

Company NameAsston Pharmaceuticals Limited

How to apply for Asston Pharmaceuticals IPO?

  1. Step 1

    Log in to your Upstox account to access IPO investments. Next, select the current IPO section.

  2. Step 2

    Specify IPO details. Enter the number of lots and the price you wish to apply for.

  3. Step 3

    Enter UPI ID. After entering your UPI ID, click submit. This will place your bid with the exchange.

  4. Step 4

    Mandate Notification. Your UPI app will receive a mandate notification to block funds.

  5. Step 5

    Approve Request. Your funds will be blocked once you approve the mandate request on your UPI.

Asston Pharmaceuticals Limited IPO FAQs